Coral-inspired bone grafts
A coral-inspired biomimetic material could revolutionize bone repair.
Researchers at Swansea University (UK) have developed an innovative bone graft substitute inspired by coral, offering significant advancements in treating bone defects. Led by Zhidao Xia from Swansea University Medical School, the research involved collaboration with experts from the Faculty of Science and Engineering and external partners.
Bone defects resulting from fractures, tumors or non-healing injuries are a leading cause of disability worldwide. Current treatments typically involve using a patient’s own bone (autograft) or donor bone (allograft). However, these approaches face limitations such as restricted availability, potential for infection and ethical concerns.
The Swansea team addressed these challenges by leveraging advanced 3D printing technology to create a biomimetic material that replicates coral’s porous structure and chemical properties. This substitute blends seamlessly with human bone and offers several benefits. Firstly, the bone graft substitute promotes accelerated healing as the material promotes new bone formation within just 2–4 weeks. It also ensures complete integration by naturally degrading within 6–12 months, leaving behind only healthy regenerated bone. Additionally, the material is cost-effective; unlike natural coral or donor bone, it can be produced in large quantities with relative ease. These features make it a groundbreaking solution for addressing the limitations of traditional bone graft methods.
Stem cell transplant shows promise for vision loss
A novel stem cell-based corneal graft has shown the potential to partially restore sight in patients with severe vision loss.
Preclinical in vivo studies demonstrated impressive results with bone defects fully repaired within 3–6 months and a strong, healthy layer of cortical bone formed in just 4 weeks.
Many existing synthetic bone grafts lack the ability to integrate effectively, dissolve efficiently or avoid side effects like inflammation. This new material resolves these issues by closely mimicking natural bone’s structure and biological behavior.
Xia explained, “”Our invention bridges the gap between synthetic substitutes and donor bone. We’ve shown that it’s possible to create a material that is safe, effective, and scalable to meet global demand. This could end the reliance on donor bone and tackle the ethical and supply issues in bone grafting.”
The research team is now seeking partnerships with companies and healthcare organizations to bring this transformative solution to patients worldwide.